Ayurvedic Classical Medicines - Avaleha and Pak
Indo Tibetan Border Police (itbp)
SONIPAT, HARYANA
Bid Publish Date
23-Dec-2025, 8:38 am
Bid End Date
12-Jan-2026, 9:00 am
Value
₹41,66,791
Location
Progress
Quantity
126224
Category
Ayurvedic Classical Medicines - Arishta
Bid Type
Two Packet Bid
The Health and Family Welfare Department of Delhi invites bids for a comprehensive range of Ayurvedic classical medicines across multiple categories, including Arishta, Choorna, Vati/Gutika, Taila, Guggulu, Rasa, Avaleha/Pak, Asava, Kvatha, Pishti, Mandoor, Lauha, and Bhasma (Q1). Estimated value is ₹4,166,790.75 with potential quantity adjustments of up to ±25% under the option clause. Bidders should note the emphasis on pharmacopoeial standards and primary/secondary packaging details for each medicine. The procurement targets reliable suppliers capable of consistent supply to Delhi’s public health ecosystem, with emphasis on batch-specific lab reporting and shelf-life compliance. Unique aspects include adherence to pharmacy-grade labeling, labelling markings, and batch-wise analytical reports, aligned with Drugs and Cosmetics Act requirements. This tender requires ISI/Pharmacopoeial compliance and delivery readiness for the Delhi health supply chain.
Medicine names across Arishta, Choorna, Vati/Gutika, Taila, Guggulu, Rasa, Avaleha/Pak, Asava, Kvatha, Pishti, Mandoor, Lauha, Bhasma
Pharmacopoeial standard / reference standard per medicine
Primary packing unit size and secondary packing quantity
Labeling requirements and additional carton markings
Analytical lab report type for each batch
Shelf life per Drugs and Cosmetics Act (years)
Option clause permits +/-25% quantity change during contract and currency with calculated delivery time
Mandatory safety, insurance, and PPE compliance for workers
GST and past experience proofs required; non-submission leads to rejection
GST treatment to be decided by bidder; reimbursement as per actuals or quoted rate, whichever is lower
Delivery window may extend per option clause; additional time = (increased quantity / original quantity) × original delivery period, minimum 30 days
Not explicitly stated in data; bidders should verify in the main tender document and ATC
Experience proof via contract copies, invoices, or client execution certificates
Compliance with pharmacopoeial standards for Ayurvedic medicines
Adequate financial capacity to handle 25% quantity fluctuations
Indo Tibetan Border Police (itbp)
SONIPAT, HARYANA
Employees State Insurance Corporation (esic)
Administrative Medical Officer Esis Mumbai
MUMBAI, MAHARASHTRA
Administrative Medical Officer Esis Mumbai
NAGPUR, MAHARASHTRA
Directorate Of Ayush
IMPHAL WEST, MANIPUR
Tender Results
Loading results...
| Category | Specification | Requirement |
|---|---|---|
| GENERAL FEATURES | Medicine name | Abhayarishta |
| GENERAL FEATURES | Pharmacopoeial standard/Reference standard | A.F.I. (B.R.) |
| PACKAGING & LABELLING | Quantity of medicine in one container/bottle (Unit pack size) (A/U) (Primary packing) | 200 ml |
| PACKAGING & LABELLING | Number of container/bottle in a pack (Secondary Packing) | 25 |
| PACKAGING & LABELLING | Additional marking requirement on the label and other cartons | GOVT. SUPPLY, NOT FOR SALE |
| CERTIFICATIONS & REPORTS | Type of analytical lab report in respect of each batch of medicine to be supplied | Test Report from Government approved lab |
| SHELF LIFE | Shelf life from the date of manufacture as per Drugs and Cosmetic Act (Years) | 10 Or higher |
Discover companies most likely to bid on this tender
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates / contract execution documents
Financial statements (audited if available)
EMD/Security deposit documentation
Technical bid documents showing compliance with pharmacopoeial standards
OEM authorization / manufacturer credentials
Lab reports and batch-wise analytics plan
Packing labels and carton marking compliance documents
Extended Deadline
12-Jan-2026, 9:00 am
Opening Date
12-Jan-2026, 9:30 am
Key insights about DELHI tender market
Bidders should prepare GST, PAN, experience documents, financial statements, and EMD proofs. Ensure pharmacopoeial standard compliance, batch-wise analytical lab reports, and OEM authorizations. The option clause allows ±25% quantity changes; delivery time calculations use the given formula with a 30-day minimum.
Submit GST certificate, PAN, audited financial statements, experience certificates or client execution letters, OEM authorization, technical bid documents, and batch-wise analytical lab reports for each medicine category. Include EMD proof or security deposit as required by the main tender.
Medicines must meet Pharmacopoeial standards or reference standards, with batch-wise lab reports confirming conformity. Labeling and carton marking must adhere to specified marking requirements, and shelf life must align with Drugs and Cosmetics Act timelines.
The purchaser may increase or decrease quantity up to 25% at contract placement and during currency. Delivery time is recalculated as (additional quantity ÷ original quantity) × original delivery period, with a minimum 30 days extension.
The estimated contract value is ₹4,166,790.75. Vendors should plan supply schedules and inventory to meet potential volume adjustments under the option clause while maintaining pharmacopoeial compliance.
For each medicine, specify unit pack size (primary packing) and number of containers per pack (secondary packing). Also ensure additional label markings on cartons and conformity with packaging standards to support batch traceability.
Sign up now to access all documents
Main Document
CATALOG Specification
CATALOG Specification
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS